STERIS plc $STE Shares Purchased by Foster Victor Wealth Advisors LLC

Key Points

• Foster Victor Wealth Advisors LLC increased its stake in STERIS plc by 7.1% in Q4 to 85,685 shares (about $23.02M), making the stock 1.4% of the firm's portfolio and its 16th-largest holding.
• Director Cynthia L. Feldmann sold 3,098 shares on March 5 at an average price of $237.21, reducing her ownership by 81.46% to 705 shares.
• STERIS reported Q4 EPS of $2.53 (in line with estimates) with revenue up 9.2%, set FY2026 guidance of $10.150–10.300 EPS, and has a consensus analyst rating of Moderate Buy with an average target of $275.20.

Foster Victor Wealth Advisors LLC raised its stake in shares of STERIS plc (NYSE:STE - Free Report) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 85,685 shares of the medical equipment provider's stock after purchasing an additional 5,656 shares during the period. STERIS accounts for 1.4% of Foster Victor Wealth Advisors LLC's portfolio, making the stock its 16th largest position. Foster Victor Wealth Advisors LLC owned about 0.09% of STERIS worth $23,019,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Nordea Investment Management AB increased its position in shares of STERIS by 259.0% in the fourth quarter. Nordea Investment Management AB now owns 51,602 shares of the medical equipment provider's stock worth $13,165,000 after acquiring an additional 37,228 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of STERIS by 9.4% in the third quarter. Dimensional Fund Advisors LP now owns 1,039,351 shares of the medical equipment provider's stock worth $257,157,000 after acquiring an additional 89,250 shares in the last quarter. Asset Management One Co. Ltd. increased its position in shares of STERIS by 5.4% in the third quarter. Asset Management One Co. Ltd. now owns 98,487 shares of the medical equipment provider's stock worth $24,366,000 after acquiring an additional 5,072 shares in the last quarter. Legal & General Group Plc increased its position in shares of STERIS by 5.3% in the third quarter. Legal & General Group Plc now owns 693,116 shares of the medical equipment provider's stock worth $171,505,000 after acquiring an additional 34,981 shares in the last quarter. Finally, Groupama Asset Managment acquired a new stake in shares of STERIS in the third quarter worth $1,163,000. Institutional investors and hedge funds own 94.69% of the company's stock.

Insider Buying and Selling at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the company's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the completion of the transaction, the director directly owned 705 shares in the company, valued at approximately $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.07% of the company's stock.

STERIS Price Performance

Shares of STE stock opened at $224.93 on Wednesday. The company has a market capitalization of $22.06 billion, a PE ratio of 31.37 and a beta of 1.07. The firm has a fifty day simple moving average of $232.92 and a 200-day simple moving average of $246.48. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. STERIS plc has a twelve month low of $209.98 and a twelve month high of $269.44.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The firm's revenue was up 9.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th were paid a $0.63 dividend. The ex-dividend date was Tuesday, February 17th. This represents a $2.52 annualized dividend and a dividend yield of 1.1%. STERIS's dividend payout ratio is 35.15%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on STE shares. Weiss Ratings reissued a "buy (b)" rating on shares of STERIS in a research report on Friday, January 9th. Wall Street Zen lowered shares of STERIS from a "strong-buy" rating to a "buy" rating in a research report on Saturday, March 28th. Six investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, STERIS currently has a consensus rating of "Moderate Buy" and an average target price of $275.20.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.